Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Dynamic expressions of Beclin 1 and tyrosine hydroxylase in different areas of 6-hydroxydopamine-induced Parkinsonian rats.

Zhang S, Xue ZF, Huang LP, Fang RM, He YP, Li L, Fang YQ.

Cell Mol Neurobiol. 2013 Oct;33(7):973-81. doi: 10.1007/s10571-013-9964-1. Epub 2013 Jul 19.

PMID:
23868341
[PubMed - indexed for MEDLINE]
2.

Involvement of brain endogenous histamine in the degeneration of dopaminergic neurons in 6-hydroxydopamine-lesioned rats.

Liu CQ, Chen Z, Liu FX, Hu DN, Luo JH.

Neuropharmacology. 2007 Dec;53(7):832-41. Epub 2007 Aug 25.

PMID:
17919665
[PubMed - indexed for MEDLINE]
3.

1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum.

Sanchez B, Relova JL, Gallego R, Ben-Batalla I, Perez-Fernandez R.

J Neurosci Res. 2009 Feb 15;87(3):723-32. doi: 10.1002/jnr.21878.

PMID:
18816795
[PubMed - indexed for MEDLINE]
4.

Rosiglitazone, a PPAR-γ agonist, protects against striatal dopaminergic neurodegeneration induced by 6-OHDA lesions in the substantia nigra of rats.

Lee EY, Lee JE, Park JH, Shin IC, Koh HC.

Toxicol Lett. 2012 Sep 18;213(3):332-44. doi: 10.1016/j.toxlet.2012.07.016. Epub 2012 Jul 27.

PMID:
22842585
[PubMed - indexed for MEDLINE]
6.

A novel therapeutic approach to 6-OHDA-induced Parkinson's disease in rats via supplementation of PTD-conjugated tyrosine hydroxylase.

Wu SP, Fu AL, Wang YX, Yu LP, Jia PY, Li Q, Jin GZ, Sun MJ.

Biochem Biophys Res Commun. 2006 Jul 21;346(1):1-6. Epub 2006 May 2.

PMID:
16762325
[PubMed - indexed for MEDLINE]
7.

Triple transduction with adeno-associated virus vectors expressing tyrosine hydroxylase, aromatic-L-amino-acid decarboxylase, and GTP cyclohydrolase I for gene therapy of Parkinson's disease.

Shen Y, Muramatsu SI, Ikeguchi K, Fujimoto KI, Fan DS, Ogawa M, Mizukami H, Urabe M, Kume A, Nagatsu I, Urano F, Suzuki T, Ichinose H, Nagatsu T, Monahan J, Nakano I, Ozawa K.

Hum Gene Ther. 2000 Jul 20;11(11):1509-19.

PMID:
10945765
[PubMed - indexed for MEDLINE]
8.

Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease.

Zheng JS, Tang LL, Zheng SS, Zhan RY, Zhou YQ, Goudreau J, Kaufman D, Chen AF.

Brain Res Mol Brain Res. 2005 Mar 24;134(1):155-61.

PMID:
15790539
[PubMed - indexed for MEDLINE]
9.

Therapeutic effects of astrocytes expressing both tyrosine hydroxylase and brain-derived neurotrophic factor on a rat model of Parkinson's disease.

Wang ZH, Ji Y, Shan W, Zeng B, Raksadawan N, Pastores GM, Wisniewski T, Kolodny EH.

Neuroscience. 2002;113(3):629-40.

PMID:
12150782
[PubMed - indexed for MEDLINE]
10.

[Alternation of proteins in brain of Parkinson's disease model rats after the transplantation of TH-NTN gene modified bone marrow mesenchymal stem cells].

Huang Y, Chang C, Zhang JW, Gao XQ.

Zhonghua Yi Xue Za Zhi. 2012 Sep 4;92(33):2353-6. Chinese.

PMID:
23158567
[PubMed - indexed for MEDLINE]
11.

Effect of Bushen Huoxue Decoction on the orphan receptor and tyrosine hydroxylase in the brain of rats with Parkinson's disease.

Yang MH, Wang HM, Liu Y.

Chin J Integr Med. 2011 Jan;17(1):43-7. doi: 10.1007/s11655-011-0618-1. Epub 2011 Jan 22.

PMID:
21258896
[PubMed - indexed for MEDLINE]
12.

Expression of tyrosine hydroxylase in an immortalized human fetal astrocyte cell line; in vitro characterization and engraftment into the rodent striatum.

Tornatore C, Baker-Cairns B, Yadid G, Hamilton R, Meyers K, Atwood W, Cummins A, Tanner V, Major E.

Cell Transplant. 1996 Mar-Apr;5(2):145-63.

PMID:
8689028
[PubMed - indexed for MEDLINE]
13.

N-terminal tripeptide of IGF-1 (GPE) prevents the loss of TH positive neurons after 6-OHDA induced nigral lesion in rats.

Guan J, Krishnamurthi R, Waldvogel HJ, Faull RL, Clark R, Gluckman P.

Brain Res. 2000 Mar 24;859(2):286-92.

PMID:
10719076
[PubMed - indexed for MEDLINE]
14.

[Expression of foreign tyrosine hydroxylase gene in the rat model of Parkinson's disease].

Jiang ZH, Ni ZM, Zhou CF, Cao L, Zheng ZC, Liu XY, Zhao YC, Chen SD.

Sheng Li Xue Bao. 1997 Apr;49(2):141-5. Chinese.

PMID:
9812848
[PubMed - indexed for MEDLINE]
15.

Time course of striatal changes induced by 6-hydroxydopamine lesion of the nigrostriatal pathway, as studied by combined evaluation of rotational behaviour and striatal Fos expression.

Labandeira-Garcia JL, Rozas G, Lopez-Martin E, Liste I, Guerra MJ.

Exp Brain Res. 1996 Feb;108(1):69-84.

PMID:
8721156
[PubMed - indexed for MEDLINE]
16.

Tyrosine hydroxylase cells appearing in the mouse striatum after dopamine denervation are likely to be projection neurones regulated by L-DOPA.

Darmopil S, Muñetón-Gómez VC, de Ceballos ML, Bernson M, Moratalla R.

Eur J Neurosci. 2008 Feb;27(3):580-92. doi: 10.1111/j.1460-9568.2008.06040.x.

PMID:
18279311
[PubMed - indexed for MEDLINE]
17.
18.

Alterations in 5-HT2A receptor binding in various brain regions among 6-hydroxydopamine-induced Parkinsonian rats.

Li Y, Huang XF, Deng C, Meyer B, Wu A, Yu Y, Ying W, Yang GY, Yenari MA, Wang Q.

Synapse. 2010 Mar;64(3):224-30. doi: 10.1002/syn.20722.

PMID:
19862688
[PubMed - indexed for MEDLINE]
19.

6-Hydroxydopamine-induced lesions in a rat model of hemi-Parkinson's disease monitored by magnetic resonance imaging.

Kondoh T, Bannai M, Nishino H, Torii K.

Exp Neurol. 2005 Mar;192(1):194-202.

PMID:
15698634
[PubMed - indexed for MEDLINE]
20.

Dopamine cell degeneration induced by intraventricular administration of 6-hydroxydopamine in the rat: similarities with cell loss in parkinson's disease.

Rodríguez M, Barroso-Chinea P, Abdala P, Obeso J, González-Hernández T.

Exp Neurol. 2001 May;169(1):163-81.

PMID:
11312569
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk